A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Wang, MD
University of Colorado, Denver
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Multiprofile Hospital for Active Treatment "sveti Georgi"
Plovdiv, Bulgaria
- University Hospital Motol
Prague, Czechia
- Hematology of Department Hemophilia and Thromboses Center
Tbilisi, Georgia
- Worthwhile Clinical Trials
Benoni, South Africa
- National Specialized Children'S Hospital Okhmatdyt, Centre for Hemostatic Pathology (ukraine)
Kyiv, Ukraine
- Institute of Blood Pathology and Transfusion Medicine
Lviv, Ukraine
- University of Colorado Denver Hemophilia & Thrombosis Center
Aurora, Colorado, United States
- Jimmy Everest Center for Cancer and Bleeding Disorders
Oklahoma City, Oklahoma, United States
- Ut Southwestern Medical Center at Dallas / Children'S Medical Center
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Dec 2015
- Primary completion
- 30 Jun 2017
- Completion
- 30 Aug 2017
- Last update posted
- 25 Feb 2022
- Registered enrollment
- 25
- Registry id
- NCT02448680
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.